BioSig Technologies (NASDAQ:BSGM) Releases Earnings Results

BioSig Technologies (NASDAQ:BSGM) released its earnings results on Wednesday. The company reported ($0.30) EPS for the quarter, reports. The company had revenue of $0.01 million during the quarter.

BioSig Technologies Stock Down 3.9 %

BSGM stock traded down $0.02 during trading on Friday, hitting $0.48. 20,033 shares of the company traded hands, compared to its average volume of 559,440. The stock’s 50-day simple moving average is $0.44 and its 200 day simple moving average is $0.91. BioSig Technologies has a 1 year low of $0.20 and a 1 year high of $6.89.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in BioSig Technologies stock. Armistice Capital LLC bought a new position in shares of BioSig Technologies, Inc. (NASDAQ:BSGM) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 5,600,000 shares of the company’s stock, valued at approximately $2,660,000. Armistice Capital LLC owned 62.36% of BioSig Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.16% of the company’s stock.

About BioSig Technologies

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.